ИСТИНА

Philippe M.

Соавторы: Kubo M., Бредер В.В., Chartrain I., Fink R., Jeon S., Qin S., Zhu A., Узбеков Р.Э., Arlot-Bonnemains Y., Bouattour M., Burkhardt M., Chen E., Danen A.L. показать полностью..., Ducreux M., Ellis L., Fonn, Fuertes E., Gally P., Garrido A., Julie D., Kırmac M., Masafumi M., Mulak J., Müller F., Ogasawara S., Peralta D.F., Perret E., Porley R.D., Saira K., Siegel D., Spitale D., Thomas B., Valente E.B., Ye, de Souza A.M., Ştefănuţ S., Ли Ю.Р., Федосов В.Э., Чан С., Чернядьева И.В., Aisyah M., Alataş M., Alegro A., Almeida L.A., Aslan G., Asthana A.K., Batan N., Baumhauer A., Bačkor M., Bednarek-Ochyra H., Beijing L.I., Bronowicki J., Brui E.A., Bruno A.D., CHEN H., Caruso G., Chen S., Cheng A., Cheng A., Cheng A., Cheng A., Cheng A., Cimerman Ž.L., Couturier A., Doree M., Dragićević S., Ebinghaus M., Erata H., Erdağ A., Evangelista M., Ezer T., Feletti T.A., Flores J.R., Giet R., Granato D., Guodong Z., György, Hodson A., Hofbauer W.K., Huang Y., Jean-Christophe C., Jennifer L., Kiebacher T., Kim T., Kim T., Komínková Z., Krajšek S.S., Kurzthaler M., Kučera J., Köckinger H., Kürschner H., Le G.R., LeBerre M., Lebouvier M., Lee G.E., Long D., Ma R., Manju C.N., Manjula K.M., Mikulášková E., Morin N., Mufeed B., Muñoz J.A., Nair M.C., Narang J., Natcheva R., Nobis M., Norhazrina N., Norquist J.M., Ochyra R., Oliván G., Ollivier-Hourmand I., Plášek V., Prigent C., Rawat K.K., Reinhardt R., Reiser G., Roghi C., Ros R., Rosmorduc O., Ross A.J., Ryoo B., Ryoo B., Sabovljevic M.S., Sahu V., Schäfer-Verwimp A., Segota V., Song T., Srivastava P., Suárez G.M., Sérgio C., Söderström L., Tabua M., Vilnet A.A., Wang S., Wang Y., Werner J., Winter G., Xu D., Xu D., Yokosuka O., Zagorodniuk N., von_Konrat M., Özenoğlu H., Афонина О.М., Баишева Э.З., Брюн С.П., Жу, Игнатов М.С., Касем Ф.М., Колтышева Д.Е., Кузнецова О.И., Мамонтов Ю.С., Потемкин А.Д., Ребриев Ю.А., Холод С.С., Шкурко А.В., ред ).

10 статей

Количество цитирований статей в журналах по данным Web of Science: 248, Scopus: 261

IstinaResearcherID (IRID): 7502813

Деятельность

• Статьи в журналах

  • 
    • 2022 New national and regional bryophyte records, 69
    • Ellis L.T., Afonina O.M., Czernyadjeva I.V., Alegro A., Šegota V., Boiko M., Zagorodniuk N., Burghardt M., Alataş M., Aslan G., Batan N., Dragićević S., Erata H., Kırmacı M., Özenoğlu H., Evangelista M., Valente E.B., Feletti T.A., Ezer T., Fedosov V.E., Fuertes E., Oliván G., Natcheva R., Gospodinov G., Hodgson A., Kiebacher T., Köckinger H., von Konrat M., Krajšek S.S., Cimerman Ž.L., Kučera J., Mikulášková E., Müller F., Muñoz J., Ochyra R., Peralta D.F., Philippe M., Porley R.D., Rawat K.K., Paul R.R., Ros R.M., Werner O., Schäfer-Verwimp A., Sérgio C., Shkurko A.V., Söderström L., de Souza A.M., Spitale D., Ștefănuţ S., Tabua M., Winter G.
    • в журнале Journal of Bryology, издательство Maney Publishing (United Kingdom), том 44, № 1, с. 87-102 DOI
  • • 2021 Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
    • Galle Peter R., Finn Richard S., Qin Shukui, Ikeda Masafumi, Zhu Andrew X., Kim Tae-You, Kudo Masatoshi, Breder Valeriy, Merle Philippe, Kaseb Ahmed, Li Daneng, Mulla Sohail, Verret Wendy, Xu Derek-Zhen, Hernandez Sairy, Ding Beiying, Liu Juan, Huang Chen, Lim Ho Yeong, Cheng Ann-Lii, Ducreux Michel
    • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 22, № 7, с. 991-1001 DOI
  • • 2020 Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    • Finn Richard S., Qin Shukui, Ikeda Masafumi, Galle Peter R., Ducreux Michel, Kim Tae-You, Kudo Masatoshi, Breder Valeriy, Merle Philippe, Kaseb Ahmed O., Li Daneng, Verret Wendy, Xu Derek-Zhen, Hernandez Sairy, Liu Juan, Huang Chen, Mulla Sohail, Wang Yulei, Lim Ho Yeong, Zhu Andrew X., Cheng Ann-Lii
    • в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 382, № 20, с. 1894-1905 DOI
  • • 2020 Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240
    • Ryoo Baek-Yeol, Merle Philippe, Kulkarni Amit S., Cheng Ann-Lii, Bouattour Mohamed, Lim Ho Yeong, Breder Valeriy, Edeline Julien, Chao Yee, Ogasawara Sadahisa, Yau Thomas, Garrido Marcelo, Chan Stephen L., Daniele Bruno, Norquist Josephine M., Chen Erluo, Siegel Abby B., Zhu Andrew X., Finn Richard S., Kudo Masatoshi
    • в журнале Cancer, издательство John Wiley & Sons Inc. (United States), том 127, № 6, с. 865-874 DOI
  • • 2020 Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
    • Finn Richard S., Ryoo Baek-Yeol, Merle Philippe, Kudo Masatoshi, Bouattour Mohamed, Lim Ho Yeong, Breder Valeriy, Edeline Julien, Chao Yee, Ogasawara Sadahisa, Yau Thomas, Garrido Marcelo, Chan Stephen L., Knox Jennifer, Daniele Bruno, Ebbinghaus Scot W., Chen Erluo, Siegel Abby B., Zhu Andrew X., Cheng Ann-Lii
    • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 38, № 3, с. 193-202 DOI
  • 
    • 2019 New national and regional bryophyte records, 59
    • Ellis L.T., Almeida L.A., Peralta D.F., Bačkor M., Baisheva E.Z., Bednarek-Ochyra H., Burghardt M., Czernyadjeva I.V., Kholod S.S., Potemkin A.D., Erdağ A., Kırmac M., Fedosov V.E., Ignatov M.S., Koltysheva D.E., Flores J.R., Fuertes E., Goga M., Guo S.L., Hofbauer W.K., Kurzthaler M., Kürschner H., Kuznetsova O.I., Lebouvier M., Long D.G., Mamontov Yu S., Manjula K.M., Manju C.N., Mufeed B., Müller F., Nair M.C., Nobis M., Norhazrina N., Aisyah M., Lee G.E., Philippe M., Philippov D.A., Plášek V., Komínková Z., Porley R.D., Rebriev Yu A., Sabovljević M.S., de Souza A.M., Valente E.B., Spitale D., Srivastava P., Sahu V., Asthana A.K., Ştefănuţ S., Suárez G.M., Vilnet A.A., Yao K.Y., -Ch Zhao J.
    • в журнале Journal of Bryology, издательство Maney Publishing (United Kingdom), том 41, № 2, с. 177-194 DOI
  • • 2017 Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
    • Bruix Jordi, Qin Shukui, Merle Philippe, Granito Alessandro, Huang Yi-Hsiang, Bodoky György, Pracht Marc, Yokosuka Osamu, Rosmorduc Olivier, Breder Valeriy, Gerolami René, Masi Gianluca, Ross Paul J., Song Tianqiang, Bronowicki Jean-Pierre, Ollivier-Hourmand Isabelle, Kudo Masatoshi, Cheng Ann-Lii, Llovet Josep M., Finn Richard S., LeBerre Marie-Aude, Baumhauer Annette, Meinhardt Gerold, Han Guohong
    • в журнале The Lancet, издательство The Lancet Publishing Group (United Kingdom), том 389, № 10064, с. 56-66 DOI
  • • 1999 Kinetic analysis of cell population growth during cultivation in vitro
    • Uzbekov R.E., Arlot-Bonnemains Y., Chartrain I., Philippe M.
    • в журнале Membrane & cell biology, издательство Harwood Academic Publishers (Switzerland), том 12, № 6, с. 773-782
  • 
    • 1998 Cell cycle analysis and synchronization of the Xenopus cell line XL2
    • Uzbekov R., Chartrain I., Philippe M., Arlot-Bonnemains Y.
    • в журнале Experimental Cell Research, издательство Academic Press (United States), том 242, № 1, с. 60-68 DOI
  • 
    • 1998 The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly
    • Roghi C., Giet R., Uzbekov R., Morin N., Chartrain I., Le Guellec R., Couturier A., Doree M., Philippe M., Prigent C.
    • в журнале Journal of Cell Science, издательство The Company of Biologists Ltd. (United Kingdom), том 111, № 5, с. 557-572 DOI